Delivering predictive, human-relevant data to de-risk clinical trials

chiron is pioneering advanced in-vitro technologies, enabling pharmaceutical innovators to derive actionable clinical insights before conducting preclinical testing or clinical trials

What we do

Contact Research Services

Our preferred format for collaborating with the pharmaceutical industry. Tap into our cutting-edge technology and expertise by letting us do the work for you; maximum impact, minimal effort

Device Manufacturing
and Sales

Design, development, manufacturing, and sale of organ-on-chip and other advanced
in-vitro technologies

Consulting Services

Leverage our deep in-vitro expertise to accelerate your next breakthrough. With our insights and technology, we help to streamline research and unlock discoveries

Our on-chip technologies

Enabling arthritis applications using Re-Plate™

A next-generation, organ-on-chip platform that recapitulates human-like movement in-vitro

See product

Enabling oncology applications using μMass™

Designed for optimized, user-friendly culturing of 3D solid tumours; capable of so much more

See product

Our impact

Together with
pharma and academia we

Create more effective treatments

Execute quicker drug development

Reduce animal testing

Improve patient well-being

Pioneering Alternatives for Drug Development

chiron has developed an advanced in-vitro technology, which comprises of growing human cells on small devices called “chips” to test the efficacy of drugs. These ground-breaking platforms have the potential to be alternatives to animal testing in drug development.

Press Release

Are you an Industry or Academic Partner?

Get access to our technology or learn more about our research services

Thank you! Your submission has been received!